The number of organ transplants worldwide has increased slowly over the recent years. Rising prevalence of chronic diseases and organ failures are the primary drivers of the market. Increase in diseases such as diabetes and high blood pressure, which results in renal diseases, unhealthy diet and over-consumption of alcohol has provided an impetus to the growth of the market. Additionally, technological advancements which have made surgeries minimally invasive, safer and reduced cost of organ transplants has spurred the market for organ transplant. The rise in the geriatric population, rise in organ donation due to growing organ donation awareness, the high success rate of transplantation, increasing aid from private and government authorities, improving healthcare infrastructure, and wide adoption of organ transplant propel the market for organ transplantation. Extensive R&D in the field of organ transplantation and rise in transplant tourism has further fuelled the growth of the market.
Organ transplant is a surgical process in which an organ is removed from one body and grafted into another body. Organ transplant is the only treatment option in case of end-stage organ failure. The global Organ Transplantation Market by Product is set to capture a CAGR of 9.8% over the forecast period 2017-2023, reveals a study by Market Research Future (MRFR).
Competitive Landscape
Shortage characterizes the global organ transplantation market; the market is monopolistic and competitive; entry into the market is strictly prohibited by law. The eminent players operating in the market include Novartis International AG (Switzerland), Transonic (US), Astellas Pharma, Inc (Japan), OrganOX Limited (UK), Transplant Biomedical (UK), Accord Healthcare GmbH (Spain), Pfizer, Inc. (US), GlaxoSmithKline Plc. (UK), Terumo Medical Corporation (US), F. Hoffmann-La Roche Ltd. (Switzerland), Preservation Solutions, Inc. (US), Bio Med Pvt. Ltd. (US), TransMedic, Inc. (US), Sanofi (France), and Veloxis Pharmaceuticals A/S (Denmark).
Segmentation
The global organ transplantation market has been segmented based on type of organ, products, type of transplant, treatment, and end-users.
By type of organ, the market has been segmented into heart, kidney, liver, lungs and other.
By products, the market has been segmented into organ preservation solution, transplant diagnostics, tissue products and others.
By type of transplant, the market has been segmented into autograft, allograft and allotransplantation, xenograft and xenotransplantation and others.
By treatment, the market has been segmented into analgesic, immunosuppressant, and others. The immunosuppressant sub-segment has been further divided into calcineurin inhibitor, antiproliferative agents, steroids, and others. Calcineurin Inhibitors has been further segmented into tacrolimus and cyclosporine. mTOR inhibitors has been further segmented into sirolimus and enviroximes.
By end-users, the market has been segmented into hospitals, transplant centres, and others.
Regional Analysis
The key markets of the global organ transplantation market include America, Europe, Asia Pacific, and Middle East & Africa. America is dominating the organ transplantation market owing to the prevalence of chronic diseases, rise in geriatric population, wide adoption of organ transplant and robust healthcare infrastructure in the region. Europe is the second largest market for organ transplantation, followed by Asia-Pacific. Increasing investment in R&D, the emergence of many new research organizations and developed healthcare facilities has propelled the market in Europe. Asia-Pacific is emerging as a key principle market for organ transplantation due to rapid development in the healthcare sector, and presence of large disease population pool in the region. Poor economic conditions have restricted the market growth in Middle East & Africa.
Industry Trends/Updates
- Dr Robert Redfield, a transplant surgeon at UW hospital, has teamed up with another expert for using pigs as organ donors for organ transplantation. They plan to create pigs who can be customized to needs of kidney, pancreases, or another organ transplant.
- In May 2018, China was appreciated at the 71st World Health Assembly (WHA) for its model and experience in organ transplantation. China's model of organ donation and transplantation reflects strong government support and a robust healthcare sector.
- The National Institutes of Health announced the launch of a new clinical trial which might pave the way for HIV-to-HIV kidney transplant. The trail is the zenith of almost a decade of work and will include 160 kidney transplants to HIV-positive patients.
About US:
Market Research Future (MRFR) enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street,5Th Floor, New York,
New York 10013